Cargando…

Possible therapeutic targets for SARS-CoV-2 infection and COVID-19

SARS-CoV-2 infection causes COVID-19, which has emerged as a health emergency worldwide. SARS-CoV-2 infects cells by binding to ACE2 receptors and enters into the cytoplasm following its escape from endolysosomes. Once in the cytoplasm, the virus replicates and eventually causes various pathological...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Nabab, Kumar, Nirmal, Geiger, Jonathan D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414779/ https://www.ncbi.nlm.nih.gov/pubmed/37564275 http://dx.doi.org/10.46439/allergy.2.028

Ejemplares similares

mTOR: A possible therapeutic target against SARS-CoV-2 infection
por: Khan, Nabab
Publicado: (2021)

Possible Therapeutic Use of Natural Compounds Against COVID-19
por: Khan, Nabab, et al.
Publicado: (2021)

Possible Role of Adenosine in COVID-19 Pathogenesis and Therapeutic Opportunities
por: Geiger, Jonathan D., et al.
Publicado: (2020)

SARS-CoV-2 S1 Protein Induces Endolysosome Dysfunction and Neuritic Dystrophy
por: Datta, Gaurav, et al.
Publicado: (2021)

Pulmonary lipid modulation: A possible therapeutic target for SARS-CoV-2 infection
por: Mandato, Claudia, et al.
Publicado: (2021)

Role of Viral Protein U (Vpu) in HIV-1 Infection and Pathogenesis
por: Khan, Nabab, et al.
Publicado: (2021)

Neurological Manifestation of SARS-CoV-2 Induced Inflammation and Possible Therapeutic Strategies Against COVID-19
por: Kumar, Dipak, et al.
Publicado: (2021)

Possible protective role of 17β-estradiol against COVID-19
por: Khan, Nabab
Publicado: (2020)

Potential and Possible Therapeutic Effects of Melatonin on SARS-CoV-2 Infection
por: Shchetinin, Evgeny, et al.
Publicado: (2022)

Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?
por: Rossi, Francesca, et al.
Publicado: (2020)

Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection
por: Qiao, Yuanyuan, et al.
Publicado: (2023)

Possibilities of simulation of coronavirus SARS-CoV-2 by using light scattering approach
por: Hussain, Farhana, et al.
Publicado: (2023)

Mu opioid receptor-mediated release of endolysosome iron increases levels of mitochondrial iron, reactive oxygen species, and cell death
por: Halcrow, Peter W., et al.
Publicado: (2023)

Essential functional molecules associated with SARS-CoV-2 infection: Potential therapeutic targets for COVID-19
por: Rajarshi, Keshav, et al.
Publicado: (2021)

Possible Role for Bacteriophages in the Treatment of SARS-CoV-2 Infection
por: Mishra, Vijaya Nath, et al.
Publicado: (2020)

Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments
por: Khan, Nabab, et al.
Publicado: (2020)

Therapeutic Targeting of Innate Immune Receptors Against SARS-CoV-2 Infection
por: Farooq, Mariya, et al.
Publicado: (2022)

Therapeutic approaches for SARS-CoV-2 infection
por: Gupta, Ankur, et al.
Publicado: (2021)

Withania somnifera (L.) Dunal (Ashwagandha) for the possible therapeutics and clinical management of SARS-CoV-2 infection: Plant-based drug discovery and targeted therapy
por: Singh, Manali, et al.
Publicado: (2022)

SARS-CoV-2 Infection Triggers Phosphorylation: Potential Target for Anti-COVID-19 Therapeutics
por: Chatterjee, Bhaswati, et al.
Publicado: (2022)

Corrigendum to “Possible Role for Bacteriophages in the Treatment of SARS-CoV-2 Infection”
por: Mishra, Vijaya Nath, et al.
Publicado: (2022)

Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19
por: Yadav, Rohitash, et al.
Publicado: (2021)

Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike
por: Trigueiro-Louro, João, et al.
Publicado: (2020)

Integrins as Therapeutic Targets for SARS-CoV-2
por: Gressett, Timothy E., et al.
Publicado: (2022)

SARS-CoV-2 Infection: Host Response, Immunity, and Therapeutic Targets
por: Shivshankar, Pooja, et al.
Publicado: (2022)

Autophagy and SARS-CoV-2 infection: A possible smart targeting of the autophagy pathway
por: Shojaei, Shahla, et al.
Publicado: (2020)

Phosphatidylserine Receptors Enhance SARS-CoV-2 Infection: AXL as a Therapeutic Target for COVID-19
por: Bohan, Dana, et al.
Publicado: (2021)

Role of Oxidative Stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) Infection: A Review
por: Suhail, Shanzay, et al.
Publicado: (2020)

Insights into Plasmodium and SARS-CoV-2 co-infection driven neurological manifestations
por: Indari, Omkar, et al.
Publicado: (2021)

Possibility of SARS-CoV-2 Infection in the Metastatic Microenvironment of Cancer
por: Hayashi, Takuma, et al.
Publicado: (2022)

Elevation in sphingolipid upon SARS-CoV-2 infection: possible implications for COVID-19 pathology
por: Vitner, Einat B, et al.
Publicado: (2021)

Role of Divalent Cations in HIV-1 Replication and Pathogenicity
por: Khan, Nabab, et al.
Publicado: (2020)

An intranasal ASO therapeutic targeting SARS-CoV-2
por: Zhu, Chi, et al.
Publicado: (2022)

Potential Therapeutic Target and Vaccines for SARS-CoV-2
por: Hussain, Mohamed A., et al.
Publicado: (2023)

Antiviral attributes of bee venom as a possible therapeutic approach against SARS-CoV-2 infection
por: Goswami, Soumik, et al.
Publicado: (2023)

Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections
por: Fani, Mona, et al.
Publicado: (2020)

SARS-CoV-2 infection and human semen: possible modes of contamination and transmission
por: Bhattacharya, Koushik, et al.
Publicado: (2021)

Potential drug targets of SARS-CoV-2: From genomics to therapeutics
por: Shamsi, Anas, et al.
Publicado: (2021)

Identification of multipotent drugs for COVID-19 therapeutics with the evaluation of their SARS-CoV2 inhibitory activity
por: Kumar, Sugandh, et al.
Publicado: (2021)

Possible therapeutic targets and promising drugs based on unsymmetrical hetaryl-substituted porphyrins to combat SARS-CoV-2
por: Gubarev, Yury A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0c3j38fdfrj3drcrv7nsd9qd0j